Heart Disease News and Research

Latest Heart Disease News and Research

Novel target in artery plaque identified as potential therapeutic intervention

A new study by NYU Langone Medical Center researchers identified a new culprit that leads to atherosclerosis, the accumulation of fat and cholesterol that hardens into plaque and narrows arteries.

9 Jan 2012

Cameron Health's PMA application for S-ICD System submitted to FDA

Cameron Health, Inc. announced today that it has submitted the Premarket Approval application to the Food and Drug Administration for the S-ICD System, the world's only completely subcutaneous implantable defibrillator.

9 Jan 2012

Progress report on commercialization of BENLYSTA to be announced at JPMorgan Healthcare Conference

Human Genome Sciences, Inc. will today announce its priority goals for 2012 and report on progress with the commercialization of BENLYSTA (belimumab), the first approved drug for systemic lupus in 56 years, during a presentation this afternoon by H. Thomas Watkins, President and Chief Executive Officer, to financial analysts and investors at the 30th Annual JPMorgan Healthcare Conference in San Francisco.

9 Jan 2012

Middle-aged adults with diabetes have time to learn how to control hypertension

A new study suggests that middle-aged adults recently diagnosed with diabetes and hypertension have time to try to learn how to control their high blood pressure without medications, but not too much time.

9 Jan 2012

miRagen, Silence partner to assess delivery potential of novel miRNA-based therapeutics

Silence Therapeutics plc, a leading RNA interference (RNAi) therapeutics company, announces that it has signed an agreement with miRagen Therapeutics, Inc., to assess the delivery potential of Silence's proprietary DBTC delivery system with miRagen's novel microRNA-based therapeutics.

9 Jan 2012

Georgia Bio announces 2012 Deals of the Year for pharma, biopharma and medical device companies

Georgia Bio announced its 2012 Deals of the Year for pharmaceutical, biopharmaceutical and medical device companies in four categories - public and private financings, fast growing companies, acquisitions and SBIR grants - reflecting a broad range of activity.

From Medtronic 7 Jan 2012

Trail of research that led to discovery of aspirin's role in prevention of first heart attack

Charles H. Hennekens, M.D., DrPH, the first Sir Richard Doll Research Professor as well as first recipient of an endowed chair in the new Charles E. Schmidt College of Medicine at Florida Atlantic University, has published a Citation Classic in the current issue of Clinical Chemistry. Hennekens was the founding principal investigator (PI) of the landmark Physician's Health Study and was the first to demonstrate that aspirin prevents a first heart attack.

7 Jan 2012

Magellan launches two fitness products

Magellan GPS announced today the launch of its first two products in its new fitness line: Switch and Switch Up. Designed to meet the needs of runners, cyclists, and multisport athletes, the new Switch Series is a powerful, adaptable, and customizable family of crossover GPS watches that will integrate seamlessly with third party sites.

7 Jan 2012

Major tobacco company manipulates data on effects of additives in cigarettes

A new UCSF analysis of tobacco industry documents shows that Philip Morris USA manipulated data on the effects of additives in cigarettes, including menthol, obscuring actual toxicity levels and increasing the risk of heart, cancer and other diseases for smokers.

7 Jan 2012

Poor nutrition in the womb can increase risk of type 2 diabetes in later life

Researchers funded by the Biotechnology and Biological Sciences Research Council have shown one way in which poor nutrition in the womb can put a person at greater risk of developing type 2 diabetes and other age-related diseases in later life.

7 Jan 2012

Investing in smoking cessation programs can save money for Medicaid

New research by the George Washington University School of Public Health and Health Services indicates that including comprehensive tobacco cessation benefits in Medicaid insurance coverage can result in substantial savings for Medicaid programs.

7 Jan 2012

Drinking red wine in moderation may reduce risk of breast cancer

Drinking red wine in moderation may reduce one of the risk factors for breast cancer, providing a natural weapon to combat a major cause of death among U.S. women, new research from Cedars-Sinai Medical Center shows.

7 Jan 2012

Research roundup: New ethics guidelines for doctors urge cost consideration; HIV testing in teens

Today's research comes from the Annals of Internal Medicine, the Journal of the American Medical Association, the Archives of Pediatrics and Adolescent Medicine, George Washington University and the Robert Wood Johnson Foundation.

7 Jan 2012

Pearl Therapeutics completes two PT003 Phase 2b clinical studies on COPD

Pearl Therapeutics Inc. today announced the completion of two Phase 2b clinical studies of PT003, the Company's investigational inhaled combination bronchodilator product for the treatment of patients with moderate-to-severe COPD.

7 Jan 2012

Alnylam files CTA with the U.K. MHRA to initiate ALN-TTR02 Phase I trial in ATTR

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has filed a Clinical Trial Application (CTA) with the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to initiate a Phase I clinical trial with ALN-TTR02, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis.

7 Jan 2012

Third Security, Transgenomic enter Convertible Promissory Note Purchase Agreement

Transgenomic, Inc. today announced that it has entered into a Convertible Promissory Note Purchase Agreement in the aggregate amount of $3.0 million with entities associated with Third Security, LLC, a leading life sciences investment firm.

7 Jan 2012

CMS assigns permanent J-code for Savient's KRYSTEXXA to treat RCG

Savient Pharmaceuticals, Inc. today announced that a product-specific billing code, or permanent J-code, for KRYSTEXXA (pegloticase) became available on January 1, 2012.

7 Jan 2012

Annual screening tests do not decrease deaths from prostate cancer

There's new evidence that annual prostate cancer screening does not reduce deaths from the disease, even among men in their 50s and 60s and those with underlying health conditions, according to new research led by Washington University School of Medicine in St. Louis.

6 Jan 2012

Non-eosinophilic disease more prevalent in patients with mild-to-moderate asthma

A large percentage of patients with mild-to-moderate asthma have persistently non-eosinophilic disease which may not respond to currently available anti-inflammatory treatments, according to a new study.

6 Jan 2012

Scottsdale Healthcare is first in Arizona to perform TAVR procedure

Scottsdale Healthcare Osborn Medical Center is the first hospital in Arizona to perform a new nonsurgical heart valve replacement procedure, the Transcatheter Aortic Valve Replacement (TAVR). TAVR valves are inserted via a catheter through the femoral artery, without requiring open heart surgery.

6 Jan 2012

Heart Disease News and Research

Latest Heart Disease News and Research

Novel target in artery plaque identified as potential therapeutic intervention

Cameron Health's PMA application for S-ICD System submitted to FDA

Progress report on commercialization of BENLYSTA to be announced at JPMorgan Healthcare Conference

Middle-aged adults with diabetes have time to learn how to control hypertension

miRagen, Silence partner to assess delivery potential of novel miRNA-based therapeutics

Georgia Bio announces 2012 Deals of the Year for pharma, biopharma and medical device companies

Trail of research that led to discovery of aspirin's role in prevention of first heart attack

Magellan launches two fitness products

Major tobacco company manipulates data on effects of additives in cigarettes

Poor nutrition in the womb can increase risk of type 2 diabetes in later life

Investing in smoking cessation programs can save money for Medicaid

Drinking red wine in moderation may reduce risk of breast cancer

Research roundup: New ethics guidelines for doctors urge cost consideration; HIV testing in teens

Pearl Therapeutics completes two PT003 Phase 2b clinical studies on COPD

Alnylam files CTA with the U.K. MHRA to initiate ALN-TTR02 Phase I trial in ATTR

Third Security, Transgenomic enter Convertible Promissory Note Purchase Agreement

CMS assigns permanent J-code for Savient's KRYSTEXXA to treat RCG

Annual screening tests do not decrease deaths from prostate cancer

Non-eosinophilic disease more prevalent in patients with mild-to-moderate asthma

Scottsdale Healthcare is first in Arizona to perform TAVR procedure

Industry Focus eBook - Pharmaceutical manufacturing (2nd edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Heart Disease News and Research

Latest Heart Disease News and Research

Industry Focus eBook - Pharmaceutical manufacturing (2nd edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in